Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158


Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.

Andreu-Vieyra C, Lai J, Berman BP, Frenkel B, Jia L, Jones PA, Coetzee GA.

Mol Cell Biol. 2011 Dec;31(23):4648-62. doi: 10.1128/MCB.05934-11. Epub 2011 Oct 3.


Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

Kang Z, Jänne OA, Palvimo JJ.

Mol Endocrinol. 2004 Nov;18(11):2633-48. Epub 2004 Aug 12.


Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.

Jia L, Shen HC, Wantroba M, Khalid O, Liang G, Wang Q, Gentzschein E, Pinski JK, Stanczyk FZ, Jones PA, Coetzee GA.

Mol Cell Biol. 2006 Oct;26(19):7331-41.


Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.

Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA.

Mol Cancer Res. 2003 Mar;1(5):385-92.


Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.

Hsieh CL, Fei T, Chen Y, Li T, Gao Y, Wang X, Sun T, Sweeney CJ, Lee GS, Chen S, Balk SP, Liu XS, Brown M, Kantoff PW.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.


Androgen receptor responsive enhancers are flanked by consistently-positioned H3-acetylated nucleosomes.

Berman BP, Frenkel B, Coetzee GA, Jia L.

Cell Cycle. 2010 Jun 1;9(11):2249-50. Epub 2010 Jun 1. No abstract available.


Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.

Liu Y, Majumder S, McCall W, Sartor CI, Mohler JL, Gregory CW, Earp HS, Whang YE.

Cancer Res. 2005 Apr 15;65(8):3404-9.


KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.

Yang S, Zhang J, Zhang Y, Wan X, Zhang C, Huang X, Huang W, Pu H, Pei C, Wu H, Huang Y, Huang S, Li Y.

Prostate. 2015 Jun 15;75(9):936-46. doi: 10.1002/pros.22977. Epub 2015 Mar 1.


Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.

Urbanucci A, Marttila S, Jänne OA, Visakorpi T.

Prostate. 2012 Aug 1;72(11):1223-32. doi: 10.1002/pros.22473. Epub 2011 Dec 27.


Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer.

Taberlay PC, Statham AL, Kelly TK, Clark SJ, Jones PA.

Genome Res. 2014 Sep;24(9):1421-32. doi: 10.1101/gr.163485.113. Epub 2014 Jun 10.


CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.

Seo WY, Jeong BC, Yu EJ, Kim HJ, Kim SH, Lim JE, Kwon GY, Lee HM, Kim JH.

Nucleic Acids Res. 2013 Oct;41(18):8526-36. doi: 10.1093/nar/gkt644. Epub 2013 Jul 25.


Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.

Wu D, Sunkel B, Chen Z, Liu X, Ye Z, Li Q, Grenade C, Ke J, Zhang C, Chen H, Nephew KP, Huang TH, Liu Z, Jin VX, Wang Q.

Nucleic Acids Res. 2014 Apr;42(6):3607-22. doi: 10.1093/nar/gkt1382. Epub 2014 Jan 13.


Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity.

Jia L, Berman BP, Jariwala U, Yan X, Cogan JP, Walters A, Chen T, Buchanan G, Frenkel B, Coetzee GA.

PLoS One. 2008;3(11):e3645. doi: 10.1371/journal.pone.0003645. Epub 2008 Nov 10.


Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.

Takayama K, Tsutsumi S, Katayama S, Okayama T, Horie-Inoue K, Ikeda K, Urano T, Kawazu C, Hasegawa A, Ikeo K, Gojyobori T, Ouchi Y, Hayashizaki Y, Aburatani H, Inoue S.

Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4.


Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells.

Ianculescu I, Wu DY, Siegmund KD, Stallcup MR.

J Biol Chem. 2012 Feb 3;287(6):4000-13. doi: 10.1074/jbc.M111.300194. Epub 2011 Dec 15. Erratum in: J Biol Chem. 2012 Oct 19;287(43):35985.


Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.

Decker KF, Zheng D, He Y, Bowman T, Edwards JR, Jia L.

Nucleic Acids Res. 2012 Nov;40(21):10765-79. doi: 10.1093/nar/gks888. Epub 2012 Sep 27.


Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.

Kollara A, Diamandis EP, Brown TJ.

J Steroid Biochem Mol Biol. 2003 Apr;84(5):493-502.


Long terminal repeats act as androgen-responsive enhancers for the PSA-kallikrein locus.

Lawrence MG, Stephens CR, Need EF, Lai J, Buchanan G, Clements JA.

Endocrinology. 2012 Jul;153(7):3199-210. doi: 10.1210/en.2012-1267. Epub 2012 May 17.


HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.

Axlund SD, Lambert JR, Nordeen SK.

Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.

Items per page

Supplemental Content

Support Center